Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma.
Robert I HaddadTanguy Y SeiwertLaura Q M ChowShilpa GuptaJared WeissIris GluckJoseph P EderBarbara BurtnessMakoto TaharaBhumsuk KeamHyunseok KangKei MuroAndrew AlbrightRobin MoggMark AyersLingkang HuangJared LuncefordRazvan CristescuJonathan ChengRanee MehraPublished in: Journal for immunotherapy of cancer (2022)
NCT01848834.